The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccines Against Malaria: Hope in a Gathering Storm
Appendix
Workshop Agenda
INSTITUTE OF MEDICINE
National Academy of Sciences
Board on International Health
Board on Health Promotion and Disease Prevention
Workshop on Malaria Vaccines
19–20 October 1995
Cecil and Ida Green Building, Room 104
2001 Wisconsin Avenue, N.W.
Washington, DC 20007
(202) 334-3904
AGENDA
19 October 1995
8:30 a.m.–8:45 a.m.
Welcome and Introductions
Philip Russell, Chair, IOM Committee on Malaria Vaccines
8:45 a.m.–10:45 a.m.
SESSION I: SETTING THE STAGE
(8:45 a.m.–9:15 a.m.)
Malaria: The Deteriorating Situation
Donald Krogstad, Tulane University School of Public Health and Tropical Medicine, USA
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 27
Vaccines Against Malaria: Hope in a Gathering Storm
Appendix
Workshop Agenda
INSTITUTE OF MEDICINE
National Academy of Sciences
Board on International Health
Board on Health Promotion and Disease Prevention
Workshop on Malaria Vaccines
19–20 October 1995
Cecil and Ida Green Building, Room 104
2001 Wisconsin Avenue, N.W.
Washington, DC 20007
(202) 334-3904
AGENDA
19 October 1995
8:30 a.m.–8:45 a.m.
Welcome and Introductions
Philip Russell, Chair, IOM Committee on Malaria Vaccines
8:45 a.m.–10:45 a.m.
SESSION I: SETTING THE STAGE
(8:45 a.m.–9:15 a.m.)
Malaria: The Deteriorating Situation
Donald Krogstad, Tulane University School of Public Health and Tropical Medicine, USA
(9:15 a.m.–9:45 a.m.)
The Promise of Malaria Vaccines
Jerald Sadoff, Merck Research Laboratories, USA
OCR for page 28
Vaccines Against Malaria: Hope in a Gathering Storm
(9:45 a.m.–10:05 a.m.)
Malaria Vaccines in the Field: A Perspective from the Africa Malaria Vaccine Testing Network
Wenceslaus Kilama, The African Malaria Vaccine Testing Network, Tanzania
(10:05 a.m.–10:30 a.m.)
Discussion
Moderator: Philip Russell
10:30 a.m.–11:00 a.m.
Break
11:00 a.m.–12:00 p.m.
SESSION II: MALARIA AS A PARADIGM
Stephen Hoffman, Naval Medical Research Institute, USA
(11:40 a.m.–12:00 p.m.)
Discussion
Moderator: Louis Miller, National Institutes of Health, USA
12:00 p.m.–1:00 p.m.
Lunch
1:00 p.m.–3:30 p.m.
SESSION III: CURRENT APPROACHES TO MALARIA VACCINE DEVELOPMENT
(1:00 p.m.–1:25 p.m.)
Preerythrocytic Vaccines
Ruth Nussenzweig, New York University Medical Center, USA
(5 min.)
Questions
(1:30 p.m.–1:55 p.m.)
Erythrocytic Vaccines
Graham Brown, The Walter and Eliza Hall Institute of Medical Research, Australia
(5 min.)
Questions
(2:00 p.m.–2:25 p.m.)
Transmission Blocking Vaccines
David Kaslow, National Institutes of Health, USA
(5 min.)
Questions
(2:30 p.m.–3:30 p.m.)
Discussion: Potential Immunologic Obstacles toDevelopment of an Optimal Multi-Immune Response, Multi-Stage Malaria Vaccine
Moderator: W. R. Ballou, Walter Reed Army Institute of Research, USA
3:30 p.m.–4:00 p.m.
Break
OCR for page 29
Vaccines Against Malaria: Hope in a Gathering Storm
4:00 p.m.–5:30 p.m.
SESSION IV: ROUNDTABLE ON U.S. FEDERAL MALARIA VACCINE ACTIVITIES
Summary of Agency Activities
20 October 1995
(4:00 p.m.–4:15 p.m.)
Public Health Service
Daniel Colley, Centers for Disease Control and Prevention
(4:15 p.m.–4:30 p.m.)
Department of Defense
William Bancroft, U.S. Army Medical Research and Materiel Command
(4:30 p.m.–4:45 p.m.)
U.S. Agency for InternationalDevelopment
Carter Diggs, USAID
(4:45 p.m.–5:00 p.m.)
Federal Malaria Vaccine Coordinating Committee
Lee Hall, National Institutes of Health
(5:00 p.m.–5:30 p.m.)
Roundtable Discussion
Moderator: Lee Hall
5:30 p.m.
Reception (North Prefunction Area, directly outside meeting room)
8:30 a.m.–10:15 a.m.
SESSION V: ROUNDTABLE ON INDUSTRIAL SECTOR ACTIVITIES
(8:30 a.m.–9:00 a.m.)
Malaria Vaccine Development: A Perspective from Industry
Russell Howard, Glaxo-Wellcome
(9:00 a.m.–9:35 a.m.)
The following participants may wish to present for 5 min. each:
Ian Bathurst, LXR Biotechnology
W. Neal Burnette, Molecular Pharmaceutics Corporation
Kenneth Guito, Connaught Laboratories
Maurice Hilleman, The Merck Institute
Adeoye Olukotun, Bristol-Myers Squibb Company
John Tine, Virogenetics Corporation
OCR for page 30
Vaccines Against Malaria: Hope in a Gathering Storm
(9:35 a.m.–10:15 a.m.)
Roundtable Discussion
Moderator: Russell Howard
10:15 a.m.–10:45 a.m.
Break
10:45 a.m.–12:15 a.m.
SESSION VI: ROUNDTABLE ON INTERNATIONAL COLLABORATION
(10:45 a.m.–11:00 a.m.)
Overview of Global Malaria Vaccine Activities
Howard Engers, WHO Special Programme for Research and Training in Tropical Diseases, Switzerland
(11:00 a.m.–11:15 a.m.)
DANIDA and Commission of European Communities
Palle Jakobsen, Denmark
(11:15 a.m.–11:25 a.m.)
African Malaria Vaccine Testing Network
Wenceslaus Kilama, Tanzania
(11:25 a.m.–11:35 a.m.)
Walter and Eliza Hall Institute of Medical Research
Graham Brown, Australia
(11:35 a.m.–11:45 a.m.)
Medical Research Council
Michael Davies, Great Britain
(11:45 a.m.–12:15 p.m.)
Roundtable Discussion
Moderator: Howard Engers (session will include participants from the Roundtable on U.S. Federal Malaria Vaccine Activities)
12:15 p.m.–1:00 p.m.
SESSION VII: SUMMARY AND DISCUSSION OF FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS
Philip Russell, IOM Committee Chair
1:00 p.m.
Workshop Adjournment
1:30 p.m.–5:00 p.m.
EXECUTIVE SESSION
Workshop Committee on Malaria Vaccines
